medmix AG (MEDX)

Currency in CHF
8.73
-0.14(-1.58%)
Delayed Data·

MEDX Earnings

Latest Release
Jul 23, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
214.4M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/060.010/--214.40M/------Free Sign Up
2025/12-0.010/--222.60M/------Free Sign Up
2025/060.160/--225.40M/------Free Sign Up
2024/12-0.330/--242.70M/------Free Sign Up
2022/12-0.300/--226.50M/------Free Sign Up
2022/060.580/--250.60M/------Free Sign Up
2021/120.440/--229.00M/------Free Sign Up
2021/060.660/--228.30M/------Free Sign Up
2020/120.160/--185.20M/------Free Sign Up
2020/060.120/--166.10M/------Free Sign Up

All numbers in CHF

medmix AG Earnings Call Summary for H1/2026

  • Medmix H1 2026 revenue fell 4.9% to CHF 214.4M, but adjusted EBITDA margin rose to 20.3%, marking fifth consecutive half-year expansion.
  • Gross margin improved 120 bps to 37.8% driven by product mix and efficiency gains; Growth and Efficiency program exceeded original savings target.
  • Shares plunged 7.53% to $7.61, hitting 52-week low, as investors focused on weak sales despite profitability improvements and cash flow gains.
  • Company maintained 2026 guidance: flat to low single-digit organic growth, ~20% EBITDA margin; expects H2 return to growth with H2 recovery.
  • Mixed segment outlook: Surgery expects high single-digit growth long-term; Drug Delivery meaningful growth delayed until 2028; Beauty turnaround ongoing.
Last Updated: 2026-07-23, 03:44 a/m
Read Full Transcript

FAQ

What Is medmix's Earnings Per Share (TTM)?

The medmix EPS (TTM) is -0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.